Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Cove...(ors in Quarterly Reports on Form 10-Q we...),Health

Date:10/6/2009

ors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

(1) Soderlund K., Linder S.; Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointestinal Endoscopy, June 2006; 63: 986-995.

(2) Moss A.; Morris E.; MacMathuna P.; Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Systematic Review, January 25, 2006.

(3) Association for International Cancer Research, http://www.aicr.org.uk/PancreaticCancerFAQs.stm, August 17, 2009.

(4) Mahesh Kumar Neelala Anand, Pancreas, Adenocarcinoma.emedicine.com.

    CONTACT: Paul Donovan
             508-650-8541 (office)
             508-667-5165 (mobile)
             Media Relations
             Boston Scientific Corporation

             Larry Neumann
             508-650-8696 (office)
             Investor Relations
             Boston Scientific Corporation

SOURCE Boston Scientific Corporation

'/>"/>

SOURCE Boston Scientific Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
2. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
3. The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA -- Hynes Convention Center October 31 -- November 3, 2009
4. SPIRIT IV Results Reaffirm Strong Performance of Boston Scientific PROMUS(R) and TAXUS(R) Express(R) Stents
5. Boston Scientific Announces Schedule for European Society of Cardiology Congress
6. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
7. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
8. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
9. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
10. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
11. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine